Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:38 PM
Ignite Modification Date:
2025-12-24 @ 12:38 PM
NCT ID:
NCT03942861
Eligibility Criteria:
Inclusion Criteria:
* Definitive diagnoses of Ulcerative colitis.
* Mayo clinical score ≥8.
* Need for Hospitalization and intravenous corticosteroid treatment.
* Age between 18-70.
* Ability and willingness to give written consent and comply with study protocol.
Exclusion Criteria:
* Contraindicators for infliximab.
* Bowel infection.
* Crohn's disease.
* Ultrasonographic inflammation in terminal ileum other than backwash ileitis.
* Bowel wall thickness \<3 in Sigmoid colon.
* Minors.
* Known malignant disease.
* Pregnancy.
* Immune modulating therapy at admission apart from corticosteroids, mesalazine or azathioprine.
Contraindicators = Patients suffering from moderate to severe heart failure, hypersensitivity to murine proteins, severe bacterial infection.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03942861
Study Brief:
Protocol Section:
NCT03942861